Brief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
11/09/2026 13:07
BRIEF-Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement Sept 11 (Reuters) - Allarity Therapeutics Inc ALLR.O:
ALLARITY THERAPEUTICS ANNOUNCES STRATEGIC CAPITAL ALLOCATION FOR FILING OF SPAC REGISTRATION STATEMENT
ALLARITY THERAPEUTICS - ALLARITY ACQUISITION CORP. FILES REGISTRATION STATEMENT FOR PROPOSED IPO
ALLARITY THERAPEUTICS - PROPOSED IPO BASE OFFERING SIZE $100 MILLION, OR $115 MILLION WITH FULL OVER-ALLOTMENT
ALLARITY THERAPEUTICS - JESPER HOILAND TO SERVE AS CHAIRMAN OF ALLARITY ACQUISITION CORP. BOARD
ALLARITY THERAPEUTICS - ALLARITY ACQUISITION CORP. APPLIES TO LIST UNITS ON NASDAQ UNDER SYMBOL 'ALLNU'
Source text: ID:nGNX4zjZ13
Further company coverage: ALLR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic